Former FDA Commissioner Dr. Scott Gottlieb said the U.S. could see an increase in hantavirus cases but does not expect the situation to spiral.
This assessment comes as health officials monitor the virus's behavior to prevent a widespread outbreak and ensure public health infrastructure can manage potential surges.
Speaking on Monday, Gottlieb addressed the current risk landscape and the specific activity observed in the Midwest. He said that several patients [1] have arrived in Nebraska for treatment. According to Gottlieb, the response to these specific cases has been efficient and timely.
"The patients we’re seeing in Nebraska are being treated promptly and there’s no evidence of sustained community transmission," Gottlieb said.
While the risk of additional cases remains, Gottlieb said that the current trajectory does not indicate a systemic crisis. He said that the lack of community spread is a critical factor in maintaining stability.
"We could see more hantavirus cases, but I don't think it will get out of control," Gottlieb said.
Public health officials typically monitor hantavirus because it is often transmitted through contact with infected rodents. The ability to treat patients quickly upon arrival in medical facilities, as seen in the Nebraska cases, is essential to reducing mortality rates associated with the virus.
“"We could see more hantavirus cases, but I don't think it will get out of control."”
The focus on Nebraska suggests a localized cluster of hantavirus activity rather than a national epidemic. Because hantavirus is not typically transmitted from person to person, the absence of community transmission means the risk remains tied to environmental exposure. The primary concern for health officials is maintaining rapid diagnostic and treatment protocols to prevent isolated cases from becoming fatal.
